Citations

Clear

625 citation(s) found for "Du, Rose".

A Brief Survey on Academic Headache Centers Knowledge of and Interest in ACGME recognition of Headache Medicine Fellowships (P1.203)
Rosen, Noah , Friedman, Deborah I. , Dodick, David W.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p1.203 Get It

Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)
Aaen, Gregory , Belman, Anita , Gorman, Mark , Harris, Yolanda, Lotze, Timothy , Mar, Soe , Moodley, Manikum , Ness, Jayne , Rodriguez, M Herrera, Rose, John , Schreiner, Teri , Tillema, Jan‐Mendelt , Waltz, Michael , Casper, T. Charles , Krysko, Kristen M. , Graves, Jennifer , Rensel, Mary R. , Weinstock‐Guttman, Bianca , Rutatangwa, Alice , Benson, Leslie , Chitnis, Tanuja , Goyal, Manu S. , Krupp, Lauren , Schreiner, Teri , Waubant, Emmanuelle L.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.625 Get It

Eptinezumab Demonstrated Migraine Preventive Efficacy on Day 1 After Dosing: Closed Testing Analysis from PROMISE-1 and PROMISE-2 (617)
Gottschalk, Christopher , Tepper, Stewart J. , Cady, Roger , Smith, Jeff , Hirman, Joe, Snapinn, Steve, Dodick, David W. , Friedman, Deborah I.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.617 Get It

Rimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials (2366)
Pavlović, Jelena , Tepper, Stewart J. , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Friedman, Deborah I. , Newman, Lawrence C. , Lipton, Richard B.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.2366 Get It

Environmental Risk Factors Associated with Pediatric Neuromyelitis Optica (P02.157)
Grandhe, Sirisha, Hart, Janace, Ness, Jayne , Belman, Anita , Milazzo, Maria , Gorman, Mark , Casper, Charlie, Rose, John , Graves, Jennifer , Mowry, Ellen M. , Hart, Janace, Krupp, Lauren , Chitnis, Tanuja , Weinstock‐Guttman, Bianca , Rodriguez, Moses , Patterson, Marc C. , Casper, Charlie, Waubant, Emmanuelle L.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p02.157 Get It

Maternal Factors and Placental Pathologies Associated with a Diagnosis of Chronic Villitis
Rose, Sherrill, Nguyen, Eliza M., Melo, Valéria , Vega, Beatriz , Kazemi-Butterfield, Nazanin, Cheek‐Norgan, E. Heidi, Theiler, Regan N. , Enninga, Elizabeth Ann L. , Rose, Sherrill J, Branda, Megan E. , Cheek-Norgan, E Heidi, Enninga, Elizabeth Ann L , Theiler, Regan , Vega, Beatriz, Girard, Sylvie , Norgan, Andrew P.

Mayo Clinic

American Journal of Perinatology | December 7, 2023 | Volume: 41 | Issue: S 01 | Pages: e3351-e3362

10.1055/a-2223-3348 | PMID 38057089 Get It

Objective To evaluate maternal risk factors associated with chronic villitis of unknown etiology (VUE) and to describe cooccurring placental pathologies. Study Design A retrospective case–control study was conducted using placental pathology records from deliveries ≥ 20 weeks between 2010 and 2018. Cases were placentas with documented chronic villitis without infectious cause, hereafter called VUE. Controls were placentas without this diagnosis, matched to the cases 2:1. Maternal and neonatal demographic and clinical data were collected. Descriptive statistics are reported with Fisher's exact test or a chi-squared test, as appropriate, and multivariable conditional logistic regression was conducted. Results Our study included 352 cases with VUE and 657 controls. A diagnosis of gestational diabetes (p = 0.03) and gestational hypertension (p = 0.06) was 1.5 times more likely to occur in those with a VUE diagnosis. A trend was also seen for chronic hypertension (odds ratio [OR] = 1.7, p = 0.07) and preeclampsia (OR = 1.5, p = 0.09) compared with controls. Placentas with VUE, specifically high-grade VUE, were more likely to be small for gestational age (p = 0.01), and to be diagnosed with other placental findings including lymphoplasmacytic or chronic deciduitis (p < 0.01), maternal (p < 0.01) and fetal vascular malperfusion (p = 0.02), and chorionitis (acute or chronic; p < 0.01). Conclusion Gestational diabetes and hypertension were associated with a diagnosis of VUE, and overall, VUE placentas have more abnormal placental findings compared with control. Understanding VUE risk factors may facilitate prenatal care strategies and counseling to achieve the best outcomes for pregnant patients and their neonates. Key Points